Genomic variant in CAV1 increases susceptibility to coronary artery disease and myocardial infarction

Atherosclerosis

Volumn 246, Issue , 2016, Pages 148-156

  Chen, Shanshan ^a   Wang, Xiaojing ^a   Wang, Junhan ^a   Zhao, Yuanyuan ^a   Wang, Dan ^a   Tan, Chengcheng ^a   Fa, Jingjing ^a   Zhang, Rongfeng ^b   Wang, Fan ^a   Xu, Chaoping ^a   Huang, Yufeng ^a   Li, Sisi ^a   Yin, Dan ^a   Xiong, Xin ^a   Li, Xiuchun ^a   Chen, Qiuyun ^c,d   Tu, Xin ^a   Yang, Yanzong ^b   Xia, Yunlong ^b   Xu, Chengqi ^a   Wang, Qing K ^a,c,d   more..

^a HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

^b DALIAN MEDICAL UNIVERSITY   (China)

^c LERNER RESEARCH INSTITUTE   (United States)

^d CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Atherosclerosis; CAV1 and CAV2; Coronary artery disease (CAD) and myocardial infarction (MI); Genome wide association study (GWAS); Rs3807989; Single nucleotide polymorphism (SNP)

Indexed keywords

CAVEOLIN 1; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; MESSENGER RNA; TRIACYLGLYCEROL; CAV1 PROTEIN, HUMAN; CAV2 PROTEIN, HUMAN; CAVEOLIN 2;

ADULT; AGE; AGED; ALLELE; ARTICLE; CASE CONTROL STUDY; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; CORONARY ARTERY DISEASE; DIABETES MELLITUS; DRINKING BEHAVIOR; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GENETIC ASSOCIATION; GENETIC SUSCEPTIBILITY; GENETIC VARIABILITY; GENOTYPE; HAN CHINESE; HEART INFARCTION; HUMAN; HUMAN CELL; HYPERTENSION; INTRON; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; PRIORITY JOURNAL; PROTEIN EXPRESSION; QUANTITATIVE TRAIT LOCUS MAPPING; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SEX DIFFERENCE; SINGLE NUCLEOTIDE POLYMORPHISM; SMOKING; TRIACYLGLYCEROL BLOOD LEVEL; ASIAN CONTINENTAL ANCESTRY GROUP; BLOOD; CHINA; EPIDEMIOLOGY; ETHNOLOGY; GENE FREQUENCY; GENETIC ASSOCIATION STUDY; GENETIC DATABASE; GENETIC PREDISPOSITION; GENETICS; MYOCARDIAL INFARCTION; PHENOTYPE; RISK FACTOR; UPREGULATION;

AGED; ASIAN CONTINENTAL ANCESTRY GROUP; CASE-CONTROL STUDIES; CAVEOLIN 1; CAVEOLIN 2; CHINA; CORONARY ARTERY DISEASE; DATABASES, GENETIC; FEMALE; GENE FREQUENCY; GENETIC ASSOCIATION STUDIES; GENETIC PREDISPOSITION TO DISEASE; HUMANS; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; PHENOTYPE; POLYMORPHISM, SINGLE NUCLEOTIDE; RISK FACTORS; UP-REGULATION;

EID: 84954208324     PISSN: 00219150     EISSN: 18791484     Source Type: Journal    
DOI: 10.1016/j.atherosclerosis.2016.01.008     Document Type: Article

References (57)

1. Zhang X.H., Lu Z.L., Liu L. Coronary heart disease in China. Heart 2008, 94:1126-1131.
2. Lozano R., Naghavi M., Foreman K., Lim S., Shibuya K., Aboyans V., et al. Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet 2012, 380:2095-2128.
3. Torpy J.M., Burke A.E., Glass R.M. Coronary heart disease risk factors. JAMA 2009, 302:2388.
4. Genome-wide association study of 14,000 cases of seven common diseases and 3,000 shared controls. Nature 2007, 447:661-678. The Wellcome Trust Case Control Consortium.
5. McPherson R., Pertsemlidis A., Kavaslar N., Stewart A., Roberts R., Cox D.R., et al. A common allele on chromosome 9 associated with coronary heart disease. Science 2007, 316:1488-1491.
6. Samani N.J., Erdmann J., Hall A.S., Hengstenberg C., Mangino M., Mayer B., et al. Genomewide association analysis of coronary artery disease. N. Engl. J. Med. 2007, 357:443-453.
7. Helgadottir A., Thorleifsson G., Magnusson K.P., Gretarsdottir S., Steinthorsdottir V., Manolescu A., et al. The same sequence variant on 9p21 associates with myocardial infarction, abdominal aortic aneurysm and intracranial aneurysm. Nat. Genet. 2008, 40:217-224.
8. Willer C.J., Sanna S., Jackson A.U., Scuteri A., Bonnycastle L.L., Clarke R., et al. Newly identified loci that influence lipid concentrations and risk of coronary artery disease. Nat. Genet. 2008, 40:161-169.
9. Erdmann J., Grosshennig A., Braund P.S., Konig I.R., Hengstenberg C., Hall A.S., et al. New susceptibility locus for coronary artery disease on chromosome 3q22.3. Nat. Genet. 2009, 41:280-282.
10. Gudbjartsson D.F., Bjornsdottir U.S., Halapi E., Helgadottir A., Sulem P., Jonsdottir G.M., et al. Sequence variants affecting eosinophil numbers associate with asthma and myocardial infarction. Nat. Genet. 2009, 41:342-347.
11. Kathiresan S., Voight B.F., Purcell S., Musunuru K., Ardissino D., et al. Genome-wide association of early-onset myocardial infarction with single nucleotide polymorphisms and copy number variants. Nat. Genet. 2009, 41:334-341. Myocardial Infarction Genetics Consortium.
12. Tregouet D.A., Konig I.R., Erdmann J., Munteanu A., Braund P.S., Hall A.S., et al. Genome-wide haplotype association study identifies the SLC22A3-LPAL2-LPA gene cluster as a risk locus for coronary artery disease. Nat. Genet. 2009, 41:283-285.
13. A genome-wide association study in Europeans and South Asians identifies five new loci for coronary artery disease. Nat. Genet. 2011, 43:339-344. Coronary Artery Disease (C4D) Genetics Consortium.
14. Schunkert H., Konig I.R., Kathiresan S., Reilly M.P., Assimes T.L., Holm H., et al. Large-scale association analysis identifies 13 new susceptibility loci for coronary artery disease. Nat. Genet. 2011, 43:333-338.
15. Wang F., Xu C.Q., He Q., Cai J.P., Li X.C., Wang D., et al. Genome-wide association identifies a susceptibility locus for coronary artery disease in the Chinese Han population. Nat. Genet. 2011, 43:345-349.
16. Lu X., Wang L., Chen S., He L., Yang X., Shi Y., et al. Genome-wide association study in Han Chinese identifies four new susceptibility loci for coronary artery disease. Nat. Genet. 2012, 44:890-894.
17. Deloukas P., Kanoni S., Willenborg C., Farrall M., Assimes T.L., et al. Large-scale association analysis identifies new risk loci for coronary artery disease. Nat. Genet. 2013, 45:25-33.
18. Xu C., Yang Q., Xiong H., Wang L., Cai J., Wang F., et al. Candidate pathway-based genome-wide association studies identify novel associations of genomic variants in the complement system associated with coronary artery disease. Circ. Cardiovasc. Genet. 2014, 7:887-894.
19. Assimes T.L., Knowles J.W., Basu A., Iribarren C., Southwick A., Tang H., et al. Susceptibility locus for clinical and subclinical coronary artery disease at chromosome 9p21 in the multi-ethnic ADVANCE study. Hum. Mol. Genet. 2008, 17:2320-2328.
20. Schunkert H., Gotz A., Braund P., McGinnis R., Tregouet D.A., Mangino M., et al. Repeated replication and a prospective meta-analysis of the association between chromosome 9p21.3 and coronary artery disease. Circulation 2008, 117:1675-1684.
21. Shen G.Q., Li L., Rao S., Abdullah K.G., Ban J.M., Lee B.S., et al. Four SNPs on chromosome 9p21 in a South Korean population implicate a genetic locus that confers high cross-race risk for development of coronary artery disease. Arterioscler. Thromb. Vasc. Biol. 2008, 28:360-365.
22. Zhou L., Zhang X., He M., Cheng L., Chen Y., Hu F.B., et al. Associations between single nucleotide polymorphisms on chromosome 9p21 and risk of coronary heart disease in Chinese Han population. Arterioscler. Thromb. Vasc. Biol. 2008, 28:2085-2089.
23. Ye H., Hong Q., Li Y., Xu X., Huang Y.I., Xu L., et al. A lack of association between the rs12619285 polymorphism and coronary heart disease. Exp. Ther. Med. 2015, 9:1309-1313.
24. Lian J., Huang Y., Huang R.S., Xu L., Le Y., Yang X., et al. Meta-analyses of four eosinophil related gene variants in coronary heart disease. J. Thromb. Thrombolysis 2013, 36:394-401.
25. Guo C.Y., Gu Y., Li L., Jia E.Z., Li C.J., Wang L.S., et al. Association of SNP rs6903956 on chromosome 6p24.1 with angiographical characteristics of coronary atherosclerosis in a Chinese population. PLoS One 2012, 7:e43732.
26. Huang E.W., Peng L.Y., Zheng J.X., Wang D., Xu Q.Y., Huang L., et al. Common variants in promoter of ADTRP associate with early-onset coronary artery disease in a Southern Han Chinese population. PLoS One 2015, 10:e0137547.
27. Peden J.F., Farrall M. Thirty-five common variants for coronary artery disease: the fruits of much collaborative labour. Hum. Mol. Genet. 2011, 20:R198-R205.
28. Watkins H., Farrall M. Genetic susceptibility to coronary artery disease: from promise to progress. Nat. Rev. Genet. 2006, 7:163-173.
29. Schwencke C., Braun-Dullaeus R.C., Wunderlich C., Strasser R.H. Caveolae and caveolin in transmembrane signaling: implications for human disease. Cardiovasc Res. 2006, 70:42-49.
30. Razani B., Woodman S.E., Lisanti M.P. Caveolae: from cell biology to animal physiology. Pharmacol. Rev. 2002, 54:431-467.
31. Pojoga L.H., Underwood P.C., Goodarzi M.O., Williams J.S., Adler G.K., Jeunemaitre X., et al. Variants of the caveolin-1 gene: a translational investigation linking insulin resistance and hypertension. J. Clin. Endocrinol. Metab. 2011, 96:E1288-E1292.
32. Fernandez-Hernando C., Yu J., Suarez Y., Rahner C., Davalos A., Lasuncion M.A., et al. Genetic evidence supporting a critical role of endothelial caveolin-1 during the progression of atherosclerosis. Cell Metab. 2009, 10:48-54.
33. Peterson T.E., Guicciardi M.E., Gulati R., Kleppe L.S., Mueske C.S., Mookadam M., et al. Caveolin-1 can regulate vascular smooth muscle cell fate by switching platelet-derived growth factor signaling from a proliferative to an apoptotic pathway. Arterioscler. Thromb. Vasc. Biol. 2003, 23:1521-1527.
34. Fernandez-Hernando C., Yu J., Davalos A., Prendergast J., Sessa W.C. Endothelial-specific overexpression of caveolin-1 accelerates atherosclerosis in apolipoprotein E-deficient mice. Am. J. Pathol. 2010, 177:998-1003.
35. Frank P.G., Pavlides S., Cheung M.W., Daumer K., Lisanti M.P. Role of caveolin-1 in the regulation of lipoprotein metabolism. Am. J. Physiol. Cell Physiol. 2008, 295:C242-C248.
36. Holm H., Gudbjartsson D.F., Arnar D.O., Thorleifsson G., Thorgeirsson G., Stefansdottir H., et al. Several common variants modulate heart rate, PR interval and QRS duration. Nat. Genet. 2010, 42:117-122.
37. Pfeufer A., van Noord C., Marciante K.D., Arking D.E., Larson M.G., Smith A.V., et al. Genome-wide association study of PR interval. Nat. Genet. 2010, 42:153-159.
38. Sotoodehnia N., Isaacs A., de Bakker P.I., Dorr M., Newton-Cheh C., Nolte I.M., et al. Common variants in 22 loci are associated with QRS duration and cardiac ventricular conduction. Nat. Genet. 2010, 42:1068-1076.
39. Ellinor P.T., Lunetta K.L., Albert C.M., Glazer N.L., Ritchie M.D., Smith A.V., et al. Meta-analysis identifies six new susceptibility loci for atrial fibrillation. Nat. Genet. 2012, 44:670-675.
40. Lubitz S.A., Lunetta K.L., Lin H., Arking D.E., Trompet S., Li G., et al. Novel genetic markers associate with atrial fibrillation risk in Europeans and Japanese. J. Am. Coll. Cardiol. 2014, 63:1200-1210.
41. Shi L., Li C., Wang C., Xia Y., Wu G., Wang F., et al. Assessment of association of rs2200733 on chromosome 4q25 with atrial fibrillation and ischemic stroke in a Chinese Han population. Hum. Genet. 2009, 126:843-849.
42. Ren X., Xu C., Zhan C., Yang Y., Shi L., Wang F., et al. Identification of NPPA variants associated with atrial fibrillation in a Chinese GeneID population. Clin. Chim. Acta 2010, 411:481-485.
43. Xu C., Wang F., Wang B., Li X., Li C., Wang D., et al. Minor allele C of chromosome 1p32 single nucleotide polymorphism rs11206510 confers risk of ischemic stroke in the Chinese Han population. Stroke 2010, 41:1587-1592.
44. Cheng X., Shi L., Nie S., Wang F., Li X., Xu C., et al. The same chromosome 9p21.3 locus is associated with type 2 diabetes and coronary artery disease in a Chinese Han population. Diabetes 2011, 60:680-684.
45. Li C., Wang F., Yang Y., Fu F., Xu C., Shi L., et al. Significant association of SNP rs2106261 in the ZFHX3 gene with atrial fibrillation in a Chinese Han GeneID population. Hum. Genet. 2011, 129:239-246.
46. Li X., Huang Y., Yin D., Wang D., Xu C., Wang F., et al. Meta-analysis identifies robust association between SNP rs17465637 in MIA3 on chromosome 1q41 and coronary artery disease. Atherosclerosis 2013, 231:136-140.
47. Xiong X., Xu C., Zhang Y., Li X., Wang B., Wang F., et al. BRG1 variant rs1122608 on chromosome 19p13.2 confers protection against stroke and regulates expression of pre-mRNA-splicing factor SFRS3. Hum. Genet. 2014, 133:499-508.
48. Chen S., Wang C., Wang X., Xu C., Wu M., Wang P., Tu X., Wang Q.K. Significant association between CAV1 variant rs3807989 on 7p31 and atrial fibrillation in a Chinese Han population. J. Am. Heart Assoc. 2015, 4. 10.1161/JAHA.115.001980.
49. Frank P.G., Lee H., Park D.S., Tandon N.N., Scherer P.E., Lisanti M.P. Genetic ablation of caveolin-1 confers protection against atherosclerosis. Arterioscler. Thromb. Vasc. Biol. 2004, 24:98-105.
50. Engel D., Beckers L., Wijnands E., Seijkens T., Lievens D., Drechsler M., et al. Caveolin-1 deficiency decreases atherosclerosis by hampering leukocyte influx into the arterial wall and generating a regulatory T-cell response. FASEB J. 2011, 25:3838-3848.
51. Li G., Zhang R., Gao L., Zhang S., Dong Y., Yin X., et al. Lack of association between rs3807989 in cav1 and atrial fibrillation. Int. J. Clin. Exp. Pathol. 2014, 7:4339-4344.
52. Liu Y., Ni B., Lin Y., Chen X.G., Chen M., Hu Z., et al. The rs3807989 G/A polymorphism in CAV1 is associated with the risk of atrial fibrillation in Chinese Han populations. Pacing Clin. Electrophysiol. 2015, 38:164-170.
53. Ambrosini E., Sicca F., Brignone M.S., D'Adamo M.C., Napolitano C., Servettini I., et al. Genetically-induced dysfunctions of Kir2. 1 channels: implications for short QT3 syndrome and autism-epilepsy phenotype. Hum. Mol. Genet. 2014, 23:4875-4876.
54. Lin J., Lin S., Choy P.C., Shen X., Deng C., Kuang S., et al. The regulation of the cardiac potassium channel (HERG) by caveolin-1. Biochem. Cell Biol. 2008, 86:405-415.
55. Barbuti A., Scavone A., Mazzocchi N., Terragni B., Baruscotti M., DiFrancesco D. A caveolin-binding domain in the HCN4 channels mediates functional interaction with caveolin proteins. J. Mol. Cell Cardiol. 2012, 53:187-195.
56. Ohman E., Nilsson A., Madeira A., Sjögren B., Andrén P.E., Svenningsson P. Use of surface plasmon resonance coupled with mass spectrometry reveals an interaction between the voltage-gated sodium channel type X α-subunit and caveolin-1. J. Proteome Res. 2008, 7:5333-5338.
57. + channels allosterically regulate the NHE-1 exchanger and promote the activity of breast cancer cell invadopodia. J. Cell Sci. 2013, 126:4835-4842.